{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:07:32Z","timestamp":1779782852326,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05587-3","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:55Z","timestamp":1778861455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing of adjuvant chemoradiotherapy after resection and survival in glioblastoma: a single-centre cohort analysis"],"prefix":"10.1007","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2657-2313","authenticated-orcid":false,"given":"Clotilde","family":"Palumbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"De Schlichting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Le Lann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Leboucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eblle","family":"Habert-Dantigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Chabardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Boutonnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pasteris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Pavillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"5587_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-007-9356-9","volume":"84","author":"L Bauchet","year":"2007","unstructured":"Bauchet L, Rigau V, Mathieu-Daud\u00e9 H, Figarella-Branger D, Hugues D, Palusseau L, Bauchet F, Fabbro M, Campello C, Capelle L, Durand A, Tr\u00e9tarre B, Frappaz D, Henin D, Menei P, Honnorat J, Segnarbieux F (2007) French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 84:189\u2013199. https:\/\/doi.org\/10.1007\/s11060-007-9356-9","journal-title":"J Neurooncol"},{"key":"5587_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5587_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12885-025-13757-1","volume":"25","author":"MAM Inggas","year":"2025","unstructured":"Inggas MAM, Patel U, Wijaya JH, Otinashvili N, Menon VR, Iyer AK, Turjman T, Dadwal S, Gadaevi M, Ismayilova A, Gaddam SJ, Arya P, Upadhyay N, Kataria S (2025) The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis. BMC Cancer 25:399. https:\/\/doi.org\/10.1186\/s12885-025-13757-1","journal-title":"BMC Cancer"},{"key":"5587_CR4","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu J-J, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim C-Y, Paek S-H, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z (2017) Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA 318:2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"key":"5587_CR5","doi-asserted-by":"publisher","unstructured":"Lakomy R, Kazda T, Selingerova I, Poprach A, Pospisil P, Belanova R, Fadrus P, Vybihal V, Smrcka M, Jancalek R, Hynkova L, Muckova K, Hendrych M, Sana J, Slaby O, Slampa P (2020) Real-world evidence in glioblastoma: stupp\u2019s regimen after a decade. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.00840","DOI":"10.3389\/fonc.2020.00840"},{"key":"5587_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, Glantz M (2016) Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. JAMA Oncol 2:1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"key":"5587_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.arcmed.2013.04.004","volume":"44","author":"Y Chen","year":"2013","unstructured":"Chen Y, Hu F, Zhou Y, Chen W, Shao H, Zhang Y (2013) MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis. Arch Med Res 44:281\u2013290. https:\/\/doi.org\/10.1016\/j.arcmed.2013.04.004","journal-title":"Arch Med Res"},{"key":"5587_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190\u2013198. https:\/\/doi.org\/10.3171\/jns.2001.95.2.0190","journal-title":"J Neurosurg"},{"key":"5587_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamaoncol.2016.6020","volume":"3","author":"EH Bell","year":"2017","unstructured":"Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu A-L, Stupp R, Curran W, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A (2017) Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. JAMA Oncol 3:784\u2013792. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6020","journal-title":"JAMA Oncol"},{"key":"5587_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JEC, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"key":"5587_CR11","doi-asserted-by":"publisher","unstructured":"Sia J, Szmyd R, Hau E, Gee HE (2020) Molecular mechanisms of radiation-induced cancer cell death: a primer. Front Cell Dev Biol 8. https:\/\/doi.org\/10.3389\/fcell.2020.00041","DOI":"10.3389\/fcell.2020.00041"},{"key":"5587_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clon.2005.08.017","volume":"18","author":"NG Burnet","year":"2006","unstructured":"Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF (2006) Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol R Coll Radiol G B 18:93\u2013103. https:\/\/doi.org\/10.1016\/j.clon.2005.08.017","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"5587_CR13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/neuonc\/nov029","volume":"17","author":"AL Stensj\u00f8en","year":"2015","unstructured":"Stensj\u00f8en AL, Solheim O, Kvistad KA, H\u00e5berg AK, Salvesen \u00d8, Berntsen EM (2015) Growth dynamics of untreated glioblastomas in vivo. Neuro-Oncol 17:1402\u20131411. https:\/\/doi.org\/10.1093\/neuonc\/nov029","journal-title":"Neuro-Oncol"},{"key":"5587_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1200\/JCO.2015.61.5906","volume":"34","author":"CT Murphy","year":"2016","unstructured":"Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA (2016) Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. J Clin Oncol 34:169\u2013178. https:\/\/doi.org\/10.1200\/JCO.2015.61.5906","journal-title":"J Clin Oncol"},{"key":"5587_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2007.11.016","volume":"87","author":"Z Chen","year":"2008","unstructured":"Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ (2008) The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiother Oncol 87:3\u201316. https:\/\/doi.org\/10.1016\/j.radonc.2007.11.016","journal-title":"Radiother Oncol"},{"key":"5587_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1227\/NEU.0000000000000801","volume":"62","author":"SJ Han","year":"2015","unstructured":"Han SJ, Englot DJ, Birk H, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA (2015) Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence. Neurosurgery 62:160\u2013165. https:\/\/doi.org\/10.1227\/NEU.0000000000000801","journal-title":"Neurosurgery"},{"key":"5587_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2016.01.001","volume":"118","author":"G Louvel","year":"2016","unstructured":"Louvel G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste P-J, Dam Hieu P, Faillot T, Litre F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes J-R, Barat J-L, Langlois O, Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J (2016) Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients. Radiother Oncol J Eur Soc Ther Radiol Oncol 118:9\u201315 Club de Neuro-Oncologie of Soci\u00e9t\u00e9 Fran\u00e7aise deNeurochirurgie. https:\/\/doi.org\/10.1016\/j.radonc.2016.01.001","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"5587_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2015.11.021","volume":"118","author":"LVM Loureiro","year":"2016","unstructured":"Loureiro LVM, Victor EdaS, Callegaro-Filho D, Koch L, de O, Pontes L, de Weltman B, Rother E, Malheiros ET SMF (2016) Minimizing the uncertainties regarding the effects of delaying radiotherapy for Glioblastoma: A systematic review and meta-analysis. Radiother Oncol 118:1\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2015.11.021","journal-title":"Radiother Oncol"},{"key":"5587_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","volume":"6","author":"AR Cabrera","year":"2016","unstructured":"Cabrera AR, Kirkpatrick JP, Fiveash JB, Shih HA, Koay EJ, Lutz S, Petit J, Chao ST, Brown PD, Vogelbaum M, Reardon DA, Chakravarti A, Wen PY, Chang E (2016) Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol 6:217\u2013225. https:\/\/doi.org\/10.1016\/j.prro.2016.03.007","journal-title":"Pract Radiat Oncol"},{"key":"5587_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12885-015-1545-x","volume":"15","author":"S Adeberg","year":"2015","unstructured":"Adeberg S, Bostel T, Harrabi S, Bernhardt D, Welzel T, Wick W, Debus J, Combs SE (2015) Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma. BMC Cancer 15:558. https:\/\/doi.org\/10.1186\/s12885-015-1545-x","journal-title":"BMC Cancer"},{"key":"5587_CR21","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/neuonc\/noac193","volume":"25","author":"P Karschnia","year":"2023","unstructured":"Karschnia P, Young JS, Dono A, H\u00e4ni L, Sciortino T, Bruno F, Juenger ST, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Weller M, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rud\u00e0 R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, Berger MS, Chang SM, van den Bent M, Tonn J-C (2023) Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro-Oncol 25:940\u2013954. https:\/\/doi.org\/10.1093\/neuonc\/noac193","journal-title":"Neuro-Oncol"},{"key":"5587_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1227\/NEU.0000000000001036","volume":"78","author":"TJC Wang","year":"2016","unstructured":"Wang TJC, Jani A, Estrada JP, Ung TH, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Isaacson SR, Cheng SK, McKhann GM, Bruce JN, Lassman AB, Sisti MB (2016) Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients. Neurosurgery 78:676\u2013682. https:\/\/doi.org\/10.1227\/NEU.0000000000001036","journal-title":"Neurosurgery"},{"key":"5587_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13014-015-0478-5","volume":"10","author":"A Seidlitz","year":"2015","unstructured":"Seidlitz A, Siepmann T, L\u00f6ck S, Juratli T, Baumann M, Krause M (2015) Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol 10:172. https:\/\/doi.org\/10.1186\/s13014-015-0478-5","journal-title":"Radiat Oncol"},{"key":"5587_CR24","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3171\/2014.9.JNS14193","volume":"122","author":"MZ Sun","year":"2015","unstructured":"Sun MZ, Oh T, Ivan ME, Clark AJ, Safaee M, Sayegh ET, Kaur G, Parsa AT, Bloch O (2015) Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg 122:1144\u20131150. https:\/\/doi.org\/10.3171\/2014.9.JNS14193","journal-title":"J Neurosurg"},{"key":"5587_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clineuro.2016.10.012","volume":"151","author":"DM Randolph","year":"2016","unstructured":"Randolph DM, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo H-W, Laxton AW, Tatter SB, Debinski W, Chan MD (2016) Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Clin Neurol Neurosurg 151:73\u201378. https:\/\/doi.org\/10.1016\/j.clineuro.2016.10.012","journal-title":"Clin Neurol Neurosurg"},{"key":"5587_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/neuros\/nyx497","volume":"83","author":"VW Osborn","year":"2018","unstructured":"Osborn VW, Lee A, Garay E, Safdieh J, Schreiber D (2018) Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database. Neurosurgery 83:915\u2013921. https:\/\/doi.org\/10.1093\/neuros\/nyx497","journal-title":"Neurosurgery"},{"key":"5587_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-017-2577-7","volume":"135","author":"JK Nathan","year":"2017","unstructured":"Nathan JK, Brezzell AL, Kim MM, Leung D, Wilkinson DA, Hervey-Jumper SL (2017) Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma. J Neurooncol 135:325\u2013333. https:\/\/doi.org\/10.1007\/s11060-017-2577-7","journal-title":"J Neurooncol"},{"key":"5587_CR28","doi-asserted-by":"publisher","first-page":"i11","DOI":"10.1093\/jrr\/rrx103","volume":"59","author":"EL Pollom","year":"2018","unstructured":"Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res (Tokyo) 59:i11\u2013i18. https:\/\/doi.org\/10.1093\/jrr\/rrx103","journal-title":"J Radiat Res (Tokyo)"},{"key":"5587_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rpor.2018.09.003","volume":"24","author":"JS Marra","year":"2019","unstructured":"Marra JS, Mendes GP, Yoshinari GH, da Silva Guimar\u00e3es F, Mazin SC, de Oliveira HF (2019) Survival after radiation therapy for high-grade glioma. Rep Pract Oncol Radiother J Gt Cancer Cent Poznan Pol Soc Radiat Oncol 24:35\u201340. https:\/\/doi.org\/10.1016\/j.rpor.2018.09.003","journal-title":"Rep Pract Oncol Radiother J Gt Cancer Cent Poznan Pol Soc Radiat Oncol"},{"key":"5587_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/neuonc\/noy017","volume":"20","author":"DT Blumenthal","year":"2018","unstructured":"Blumenthal DT, Won M, Mehta MP, Gilbert MR, Brown PD, Bokstein F, Brachman DG, Werner-Wasik M, Hunter GK, Valeinis E, Hopkins K, Souhami L, Howard SP, Lieberman FS, Shrieve DC, Wendland MM, Robinson CG, Zhang P, Corn BW (2018) Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology\/Radiation Therapy Oncology Group database. Neuro-Oncol 20:966\u2013974. https:\/\/doi.org\/10.1093\/neuonc\/noy017","journal-title":"Neuro-Oncol"},{"key":"5587_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11060-019-03137-8","volume":"143","author":"VM Santos","year":"2019","unstructured":"Santos VM, Marta GN, Mesquita MC, Lopez RVM, Cavalcante ER, Feher O (2019) The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma. J Neurooncol 143:95\u2013100. https:\/\/doi.org\/10.1007\/s11060-019-03137-8","journal-title":"J Neurooncol"},{"key":"5587_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/0284186X.2019.1672893","volume":"59","author":"M Potharaju","year":"2020","unstructured":"Potharaju M, Mathavan A, Mangaleswaran B, Ghosh S, John R (2020) Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients. Acta Oncol 59:320\u2013323. https:\/\/doi.org\/10.1080\/0284186X.2019.1672893","journal-title":"Acta Oncol"},{"key":"5587_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13014-019-1272-6","volume":"14","author":"S Katsigiannis","year":"2019","unstructured":"Katsigiannis S, Krischek B, Barleanu S, Grau S, Galldiks N, Timmer M, Kabbasch C, Goldbrunner R, Stavrinou P (2019) Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol Lond Engl 14:73. https:\/\/doi.org\/10.1186\/s13014-019-1272-6","journal-title":"Radiat Oncol Lond Engl"},{"key":"5587_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jocn.2019.05.013","volume":"66","author":"MJ Amsbaugh","year":"2019","unstructured":"Amsbaugh MJ, Yusuf M, Gaskins J, Burton E, Woo S (2019) The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database. J Clin Neurosci Off J Neurosurg Soc Australas 66:92\u201399. https:\/\/doi.org\/10.1016\/j.jocn.2019.05.013","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"5587_CR35","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.21037\/tcr-20-1718","volume":"9","author":"M Zhang","year":"2020","unstructured":"Zhang M, Xu F, Ni W, Qi W, Cao W, Xu C, Chen J, Gao Y (2020) Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients. Transl Cancer Res 9:5450\u20135458. https:\/\/doi.org\/10.21037\/tcr-20-1718","journal-title":"Transl Cancer Res"},{"key":"5587_CR36","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1002\/cncr.32797","volume":"126","author":"RH Press","year":"2020","unstructured":"Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, Morgan TM, Behera M, Sengupta S, Voloschin AD, Olson JJ, Hasan S, Blumenthal DT, Curran WJ, Eaton BR, Shu H-KG, Zhong J (2020) Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification. Cancer 126:3255\u20133264. https:\/\/doi.org\/10.1002\/cncr.32797","journal-title":"Cancer"},{"key":"5587_CR37","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1038\/s41598-020-61701-z","volume":"10","author":"SM Buszek","year":"2020","unstructured":"Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C (2020) Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database. Sci Rep 10:4926. https:\/\/doi.org\/10.1038\/s41598-020-61701-z","journal-title":"Sci Rep"},{"key":"5587_CR38","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1016\/j.wneu.2019.09.122","volume":"133","author":"S Ahn","year":"2020","unstructured":"Ahn S, Park J-S, Song JH, Jeun S-S, Hong Y-K (2020) Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection. World Neurosurg 133:e640\u2013e645. https:\/\/doi.org\/10.1016\/j.wneu.2019.09.122","journal-title":"World Neurosurg"},{"key":"5587_CR39","doi-asserted-by":"publisher","first-page":"e0249486","DOI":"10.1371\/journal.pone.0249486","volume":"16","author":"DM Prost","year":"2021","unstructured":"Prost DM, Merenzon MA, G\u00f3mez-Escalante JI, Primavera A, Vargas Ben\u00edtez M, Gil AS, Marenco PM, Califano MM, Moughty Cueto C, Zaloff Dakoff JM, Colonna M, Mazz\u00f3n A, Zaninovich RS, De Crist\u00f3faro OR (2021) Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area. PLoS ONE 16:e0249486. https:\/\/doi.org\/10.1371\/journal.pone.0249486","journal-title":"PLoS ONE"},{"key":"5587_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jocn.2021.05.002","volume":"90","author":"\u0141 Magrowski","year":"2021","unstructured":"Magrowski \u0141, Nowicka E, Masri O, Tukiendorf A, Tarnawski R, Miszczyk M (2021) The survival impact of significant delays between surgery and radiochemotherapy in glioblastoma patients: A retrospective analysis from a large tertiary center. J Clin Neurosci Off J Neurosurg Soc Australas 90:39\u201347. https:\/\/doi.org\/10.1016\/j.jocn.2021.05.002","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"5587_CR41","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s12094-022-02867-y","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Guo F, Wang X, Zeng J, Hong J (2022) Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush. Clin Transl Oncol 24:2146\u20132154. https:\/\/doi.org\/10.1007\/s12094-022-02867-y","journal-title":"Clin Transl Oncol"},{"key":"5587_CR42","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1016\/j.wneu.2023.07.008","volume":"177","author":"T Natukka","year":"2023","unstructured":"Natukka T, Haapasalo J, Kivioja T, Rajala L, Raitanen J, Nevalainen J, Lahtela S-L, Nordfors K, Rauhala M, Jukkola A, Fr\u00f6sen J, Hel\u00e9n P, Auvinen A, Haapasalo H (2023) Impact of Timing of Surgery and Adjuvant Treatment on Survival of Adult IDH\u2013wild-type Glioblastoma: A Single-center Study of 392 Patients. World Neurosurg 177:e785\u2013e792. https:\/\/doi.org\/10.1016\/j.wneu.2023.07.008","journal-title":"World Neurosurg"},{"key":"5587_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11060-024-04709-z","volume":"169","author":"H Blakstad","year":"2024","unstructured":"Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggeb\u00f8 LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024) The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients. J Neurooncol 169:137\u2013145. https:\/\/doi.org\/10.1007\/s11060-024-04709-z","journal-title":"J Neurooncol"},{"key":"5587_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2478\/raon-2025-0031","volume":"59","author":"V Semiz","year":"2025","unstructured":"Semiz V, Cetinayak HO, Aydin B, Umay C, Can F (2025) Surgery to chemoradiotherapy time may not impact outcomes in glioblastoma patients treated with modern techniques: a single-institution study. Radiol Oncol 59:244\u2013251. https:\/\/doi.org\/10.2478\/raon-2025-0031","journal-title":"Radiol Oncol"},{"key":"5587_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11060-019-03120-3","volume":"142","author":"A De Barros","year":"2019","unstructured":"De Barros A, Attal J, Roques M, Nicolau J, Sol J-C, Cohen-Jonathan-Moyal E, Roux F-E (2019) Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma. J Neurooncol 142:489\u2013497. https:\/\/doi.org\/10.1007\/s11060-019-03120-3","journal-title":"J Neurooncol"},{"key":"5587_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0167-8140(00)00257-7","volume":"57","author":"V Do","year":"2000","unstructured":"Do V, Gebski V, Barton MB (2000) The effect of waiting for radiotherapy for grade III\/IV gliomas. Radiother Oncol J Eur Soc Ther Radiol Oncol 57:131\u2013136. https:\/\/doi.org\/10.1016\/s0167-8140(00)00257-7","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"5587_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-007-9426-z","volume":"85","author":"C Irwin","year":"2007","unstructured":"Irwin C, Hunn M, Purdie G, Hamilton D (2007) Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 85:339\u2013343. https:\/\/doi.org\/10.1007\/s11060-007-9426-z","journal-title":"J Neurooncol"},{"key":"5587_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12094-012-0916-x","volume":"15","author":"I Valduvieco","year":"2013","unstructured":"Valduvieco I, Verger E, Bruna J, Caral L, Pujol T, Ribalta T, Boget T, Oleaga L, Pineda E, Graus F (2013) Impact of radiotherapy delay on survival in glioblastoma. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 15:278\u2013282. https:\/\/doi.org\/10.1007\/s12094-012-0916-x","journal-title":"Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"5587_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/b:neon.0000040820.78643.0a","volume":"70","author":"S Peker","year":"2004","unstructured":"Peker S, Abacioglu U, Sun I, Yuksel M, Pamir MN (2004) Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage. J Neurooncol 70:17\u201321. https:\/\/doi.org\/10.1023\/b:neon.0000040820.78643.0a","journal-title":"J Neurooncol"},{"key":"5587_CR50","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1200\/JCO.2008.18.9035","volume":"27","author":"DT Blumenthal","year":"2009","unstructured":"Blumenthal DT, Won M, Mehta MP, Curran WJ, Souhami L, Michalski JM, Rogers CL, Corn BW (2009) Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol Off J Am Soc Clin Oncol 27:733\u2013739. https:\/\/doi.org\/10.1200\/JCO.2008.18.9035","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05587-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05587-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05587-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:58:43Z","timestamp":1779782323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05587-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5587"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05587-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of the relevant institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments (or comparable ethical standards). The study was approved by the Institutional Review Board of the Coll\u00e8ge de Neurochirurgie (IRB No. IRB00011687). In accordance with French regulations for retrospective studies, the CNIL (Commission nationale de l\u2019informatique et des libert\u00e9s) was informed pursuant to D\u00e9cret n\u00b02005\u2009\u2212\u20091309 du 20 octobre 2005, implementing Law n\u00b078\u2009\u2212\u200917 du 6 janvier 1978 on data processing, files, and liberties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Humans ethics"}},{"value":"In accordance with French regulations for retrospective studies, individual written informed consent was not required; patients were informed that their data could be used for research purposes and were included unless they expressed opposition.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}